News Column

Biotechnology Company Leverages OmniComm Systems' TrialMaster

July 13, 2014

OmniComm Systems reported that a biotechnology company, selected OmniComm's TrialMaster electronic data capture technology (EDC) to support three Phase III late stage clinical development studies.

According to a release from the company, TrialMaster will be used for an open-labeled, multicenter, safety study and two randomized, double-blind, placebo-controlled efficacy and safety studies. OmniComm's technology and processes for integrating TrialMaster with other best-of-breed solutions was a factor in selecting TrialMaster as their EDC system. This biotechnology company will integrate TrialMaster with its Interactive Response Technologies (IRT) solution. IRT solutions automate randomization and clinical supplies management and when integrated with TrialMaster EDC provides a solution.

TrialMaster noted its user interface and data capture, data management and reporting functionality was a significant factor in this company's selection of TrialMaster. TrialMaster also includes embedded eLearning, allowing researchers to learn the system and quickly and accurately initiate new clinical trials.

"This award is not only about choosing the best EDC system on the market but it is also about how well best-of-breed technology can be brought together seamlessly and efficiently," said Dr Kuno van der Post, senior vice president business development. "Our partner centric approach is clearly resonating with the market place."

OmniComm Systems is a strategic software solutions provider to the life sciences industry.

More information and complete details:

((Comments on this story may be sent to

For more stories covering the world of technology, please see HispanicBusiness' Tech Channel

Source: Professional Services Close - Up

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters